Search Results - Maria Maccecchini
- Showing 1 - 2 results of 2
-
1
A phase 1, safety, tolerability, and pharmacokinetics study of bisnorcymserine, a highly selective inhibitor of butyrylcholinesterase by Iason Tzieras, Apostolos Manolopoulos, David Tweedie, Weiming Luo, Maria Maccecchini, Josephine M. Egan, Nigel H. Greig, Dimitrios Kapogiannis
Published in Neurotherapeutics (2026-04-01)Get full text
Article -
2
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Pos... by Douglas Galasko, Martin R. Farlow, Brendan P. Lucey, Lawrence S. Honig, Donald Elbert, Randall Bateman, Jeremiah Momper, Ronald G. Thomas, Robert A. Rissman, Judy Pa, Vahan Aslanyan, Archana Balasubramanian, Tim West, Maria Maccecchini, Howard H. Feldman
Published in Alzheimer’s Research & Therapy (2024-07-01)Get full text
Article
